Synertec Corporation Ltd (ASX:SOP) Stock Falls: Here’s What Investors Need to Know

Sonal Goyal

23 October 2026 02:47 PM AEDT

Synertec Corporation Ltd (ASX:SOP) Stock Falls: Here’s What Investors Need to Know

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Synertec Corporation Ltd (ASX:SOP) was trading at A$0.069, down 9.21%, during the 23 October 2026 trading session.
On 23 September 2026, the company upgraded its FY27 Revenue guidance to A$37.5 million to A$40.0 million, from A$29.5 million to A$31.7 million.
The S&P/ASX 200 was down 0.37% at 8,760.50 at 1:16 pm AEDT on 23 October 2026.

Synertec Corporation Ltd (ASX:SOP) shares were trading at A$0.069, down 9.21%, during the 23 October 2026 trading session, well beyond the S&P/ASX 200 decline of 0.37% to 8,760.50 (down 32.70 points) at 1:16 pm AEDT. Melbourne-based Synertec describes itself as a technology design, development and engineering growth company, with Engineering and Powerhouse businesses. Its latest update was released on 23 September 2026, when it announced an upgrade to its FY27 revenue guidance. That release predates today's session and is reported here as background only.

Latest Developments

FY27 Revenue Guidance Upgraded on 23 September 2026

On 23 September 2026, Synertec announced that it was upgrading its FY27 revenue guidance to A$37.5 million to A$40.0 million, compared with previous guidance of A$29.5 million to A$31.7 million. The company said the new range is an increase of approximately A$8.0 million to A$8.3 million over the previous range.

According to the announcement, the revised range represents growth of approximately 77% to 89% on FY26 external revenue of A$21.1 million. The company also listed FY25 actual revenue of A$17.8 million.

Drivers Cited by the Company

The company said the upgrade reflects contract conversion in the Engineering business, including the A$45.5 million ANSTO Nuclear Medicine Manufacturing Program contract, together with continued growth across government, healthcare, nuclear and critical infrastructure markets. It also pointed to commercial momentum and project progression in Powerhouse, increased revenue visibility from contracted work and its industry Diversification and geographic expansion strategy.

Pipeline Commentary and Guidance Assumptions

Synertec said the ANSTO contract increased its previously disclosed Engineering pipeline of A$174 million by only approximately A$9 million, which it attributed to its probability-weighted approach to pipeline reporting. The company said the guidance upgrade is not solely attributable to ANSTO.

The company stated that the updated guidance assumes delivery of contracted work in line with current project schedules, mobilisation and execution of recently awarded contracts, continued progression of Powerhouse projects, and no material adverse changes in customer schedules, project delivery timing, economic conditions, Supply chains or foreign exchange rates. It added that it is not providing FY27 guidance for EBITDA, EBIT, NPAT or operating cash flow, and that the update relates to revenue only.

Managing Director Michael Carroll said the company was pleased to upgrade its guidance and that the outlook reflects a broader strengthening of the Business across multiple projects and customers.

About Synertec Corporation Ltd

Synertec Corporation Ltd is, in its own words, a technology design and development growth company enabling a low carbon future through innovative technology solutions. The company says it is commercialising scalable, environmentally friendly and energy efficient technology for global markets in energy, critical infrastructure and advanced manufacturing, through partnerships with a portfolio of Blue-Chip customers.

The company reports through two businesses, Engineering and Powerhouse. The announcement refers to the Engineering business serving government, healthcare, nuclear and critical infrastructure markets, including the ANSTO Nuclear Medicine Manufacturing Program contract.

Related Sector Context

Synertec operates at the intersection of engineering services and technology development, with project-based work for government and infrastructure customers. Revenue in this type of business is generally tied to contract awards, project schedules and delivery timing, which the company itself acknowledges in the assumptions behind its guidance.

The S&P/ASX 200, which tracks the 200 largest listed companies, was down 0.37% at 1:16 pm AEDT on 23 October 2026, compared with the 9.21% decline in Synertec shares during the session.

Risks to Weigh In

The FY27 guidance covers revenue only, and the company said it is not providing guidance for EBITDA, EBIT, NPAT or operating cash flow.
The guidance assumes delivery of contracted work to current project schedules and no material adverse changes in customer schedules, supply chains, economic conditions or foreign exchange rates.
The company reports a probability-weighted Engineering pipeline, and the conversion of pipeline opportunities into contracts is not assured.
Intraday share price figures reflect trading at a point in time during the session and can change before the session ends.

Catalysts on Watch

Mobilisation and execution of recently awarded contracts, including the A$45.5 million ANSTO Nuclear Medicine Manufacturing Program contract.
Continued progression of Powerhouse projects, which the company listed among its guidance assumptions.
Conversion of the Engineering pipeline of approximately A$174 million, as described by the company.
Further announcements to the ASX on contracts or trading, as the company continues its diversification and geographic expansion strategy.

Where Things Stand

Synertec shares were trading at A$0.069, down 9.21%, during the 23 October 2026 trading session, while the S&P/ASX 200 was down 0.37% at 1:16 pm AEDT. The company's latest update covered in this article, released on 23 September 2026, raised its FY27 revenue guidance to A$37.5 million to A$40.0 million. That update was released on an earlier date, and the figures in this article for today's session are intraday.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.